Effects of a GLP-1 agonist and anti-diabetic therapies on pheochromocytoma/paraganglioma growth

Related

• Nature Medicine·4 Oct 2026

  Semaglutide may protect kidneys by reducing vascular resistance

  

• Diabetes & Vascular Disease Research·4 Oct 2026

  SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

• Diabetes, Obesity & Metabolism·4 Oct 2026

  Genetically proxied GIP pathway links to lower fracture risk

• Research Square·8 Oct 2026

  Semaglutide improved heart artery function in pigs